ADM Korea Past Earnings Performance
Past criteria checks 0/6
ADM Korea's earnings have been declining at an average annual rate of -124.3%, while the Life Sciences industry saw earnings growing at 21.1% annually. Revenues have been growing at an average rate of 4.2% per year.
Key information
-124.3%
Earnings growth rate
-127.1%
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | 4.2% |
| Return on equity | -9.9% |
| Net Margin | -21.5% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How ADM Korea makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 13,790 | -2,970 | 4,490 | 1,064 |
| 30 Sep 23 | 14,557 | -2,086 | 4,369 | 1,038 |
| 30 Jun 23 | 15,320 | -1,294 | 4,158 | 857 |
| 31 Mar 23 | 15,096 | -493 | 4,059 | 721 |
| 31 Dec 22 | 14,883 | 267 | 3,804 | 587 |
| 30 Sep 22 | 15,375 | 1,149 | 3,770 | 535 |
| 30 Jun 22 | 14,374 | 963 | 4,217 | 556 |
| 31 Mar 22 | 14,005 | 1,418 | 4,174 | 544 |
| 31 Dec 21 | 13,978 | 1,923 | 4,072 | 628 |
| 30 Sep 21 | 13,415 | 2,923 | 3,896 | 616 |
| 30 Jun 21 | 13,199 | 3,504 | 3,240 | 803 |
| 31 Mar 21 | 13,049 | 3,564 | 2,919 | 756 |
Quality Earnings: A187660 is currently unprofitable.
Growing Profit Margin: A187660 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A187660's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare A187660's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A187660 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (7.5%).
Return on Equity
High ROE: A187660 has a negative Return on Equity (-9.88%), as it is currently unprofitable.